In India, the choice of photovoltaic modules is often between PERC (p-type) and TOPCon (n-type) cells. In the future ...

with first line use of advanced therapies like LUPKYNIS for three to five years. Importantly, the guidelines suggest that steroids should be rapidly tapered to 5 mg/day by six months as the highest ...

This valuable study reveals extensive binding of eukaryotic translation initiation factor 3 (eIF3) to the 3' untranslated regions (UTRs) of efficiently translated mRNAs in human pluripotent stem ...

The HTS solution can either supplement or replace the maintenance intravenous solution ... HTS must be administered through a central line. It cannot be given peripherally, because HTS in ...

Jazz Pharmaceuticals PLC (JAZZ) reports robust financial performance with significant growth in key product sales and ...

Frustrated with forklift power solution setbacks? Discover a smarter, all-in-one solution that powers fleets more efficiently ...

Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its third quarter 2024 results today. Conference call and ...

Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Hello, and welcome to the AIM ImmunoTech Third Quarter 2024 ...

Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic ...

Protocol modifications to include the use of a different taxane ... and potentiate the activity of PD-1 inhibitors in human cancer cell lines. These data led us to investigate the combination of ...